Trigger point injections for myofascial pain in terminal cancer: a randomized trial
A single TPI of a local anesthetic is safe and efficacious in inducing an immediate reduction in MPS-related pain in patients with incurable cancer. Clinical trials registration number: This study was registered with the Japan Registry of Clinical Trials (approval number: jRCTs051210132) on December 16, 2021. https://jrct.niph.go.jp/en-latest-detail/jRCTs051210132.Approval of the research protocol by a Certified Review Board: The present study was approved by the Wakayama Medical University (reference number: CRB5180004. Registered 26 May 2021).
Authors
- Hiromichi Matsuoka (ORCID: https://orcid.org/0000-0002-7276-1971)
- Hideki Ishikawa (ORCID: https://orcid.org/0000-0001-5980-698X)
- Yoshinobu Matsuda (ORCID: https://orcid.org/0000-0001-5092-9377)
- Hiroto Ishiki (ORCID: https://orcid.org/0000-0002-0800-2161)
- Mei Xing
- Kazuhiro Kosugi (ORCID: https://orcid.org/0000-0002-3330-6319)
- Hideaki Hasuo (ORCID: https://orcid.org/0000-0002-4689-1203)
- Yoshihisa Matsumoto (ORCID: https://orcid.org/0000-0003-3112-4818)
- Yasushi Akiyama (ORCID: https://orcid.org/0000-0002-6342-157X)
Institutions
- Kansai Medical University (JP)
- Kyoto Prefectural University (JP)
- Kyoto Prefectural University of Medicine (JP)
- National Cancer Centre Japan (JP)
- National Cancer Center (US)
- National Cancer Center Hospital East (JP)
- Tokyo National Hospital (JP)
- NHO Kinki Chuo Chest Medical Center (JP)
- Japanese Foundation For Cancer Research (JP)
Publication Details
- Journal
- Pain Medicine
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1093/pm/pnae084
- Citations
- 1
- Primary Topic
- Myofascial pain diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.33